Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (281-290 of 636) with videos related to

Pageof 64
Sort By:
Hepatology (Baltimore, Md.)|August 9, 2014
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective studyRohit Loomba, Tanya Wolfson, Brandon Ang, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver diseaseVeeral Ajmera, Emily R Perito, Nathan M Bass, et al.
Nutrients|March 29, 2023
Serum Fibroblast Growth Factor 21 Is Markedly Decreased following Exercise Training in Patients with Biopsy-Proven Nonalcoholic SteatohepatitisJonathan G Stine, Jaclyn E Welles, Shelley Keating, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2020
Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-AnalysisJonathan G Stine, Nagambika Munaganuru, Abbey Barnard, et al.
Journal of Hepatology|February 13, 2026
Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLDMatthew Dukewich, Laura A Wilson, Jennifer L Dodge, et al.
Science (New York, N.Y.)|February 8, 2020
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitisPeng Zhao, Xiaoli Sun, Cynthia Chaggan, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitisCyrielle Caussy, Jen-Chieh Chuang, Andrew Billin, et al.
Gastroenterology|February 25, 2026
The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol UseFederica Tavaglione, Juan Vaz, Oveis Jamialahmadi, et al.
Hepatology (Baltimore, Md.)|May 23, 2013
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trialsMazen Noureddin, Jessica Lam, Michael R Peterson, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 31, 2013
Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimationYakir S Levin, Takeshi Yokoo, Tanya Wolfson, et al.
Pageof 64

Showing results (281-290 of 636) with videos related to

Sort By:
Pageof 64
Hepatology (Baltimore, Md.)|August 9, 2014
Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective studyRohit Loomba, Tanya Wolfson, Brandon Ang, et al.
Hepatology (Baltimore, Md.)|August 18, 2016
Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver diseaseVeeral Ajmera, Emily R Perito, Nathan M Bass, et al.
Nutrients|March 29, 2023
Serum Fibroblast Growth Factor 21 Is Markedly Decreased following Exercise Training in Patients with Biopsy-Proven Nonalcoholic SteatohepatitisJonathan G Stine, Jaclyn E Welles, Shelley Keating, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 4, 2020
Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-AnalysisJonathan G Stine, Nagambika Munaganuru, Abbey Barnard, et al.
Journal of Hepatology|February 13, 2026
Longitudinal Changes in Cardiometabolic Risk Factors are Associated with Changes in Liver Stiffness in Adults with MASLDMatthew Dukewich, Laura A Wilson, Jennifer L Dodge, et al.
Science (New York, N.Y.)|February 8, 2020
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitisPeng Zhao, Xiaoli Sun, Cynthia Chaggan, et al.
Therapeutic Advances in Gastroenterology|June 12, 2020
Plasma eicosanoids as noninvasive biomarkers of liver fibrosis in patients with nonalcoholic steatohepatitisCyrielle Caussy, Jen-Chieh Chuang, Andrew Billin, et al.
Gastroenterology|February 25, 2026
The MetALD-ALD Prediction Index: A Phosphatidylethanol-Driven Biomarker Panel for Identifying Individuals With Steatotic Liver Disease and Excessive Alcohol UseFederica Tavaglione, Juan Vaz, Oveis Jamialahmadi, et al.
Hepatology (Baltimore, Md.)|May 23, 2013
Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trialsMazen Noureddin, Jessica Lam, Michael R Peterson, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 31, 2013
Effect of echo-sampling strategy on the accuracy of out-of-phase and in-phase multiecho gradient-echo MRI hepatic fat fraction estimationYakir S Levin, Takeshi Yokoo, Tanya Wolfson, et al.
Pageof 64